- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
News Roundup: September 18 to September 22
Your weekly roundup of the latest news from Drug Topics®.
Children With T1D Who Report Higher CGM Satisfaction Have Better Glycemic Control
The 3 most common issues associated with higher satisfaction were “makes adjusting insulin easier,” “helps to keep low blood sugars from happening,” and “makes me feel safer knowing that I will be warned about low blood sugar before it happens.”
Technology Tools Increase Patient Safety in the Pharmacy
From automated medication dispensing systems to telepharmacy services, technology can help reduce the risk of adverse patient events.
OTC Products, Oral Prescriptions Demonstrate Efficacy in Episodic Migraine
Although there were some differences in response after dosing, both OTC and oral prescriptions demonstrated statistically significant improvements in pain.
Pharmacy Organizations Establish Pharmacy Workforce Suicide Awareness Day
The American Society of Health-System Pharmacists (ASHP) and the American Pharmacists Association (APhA) have partnered together to establish Pharmacy Workforce Suicide Awareness Day, which will be observed annually on September 20, as part of Suicide Prevention Month.
Understaffing at CVS Pharmacies in Ohio Lead to Concerns About Patient Safety
The Ohio Board of Pharmacy found during several inspections that some CVS stores in the state had dirty conditions, a lack of control over dangerous medications, and months-long wait times for medications.
Antiseizure Medications Linked to Serious Potential Reaction, FDA Warns
November 30th 2023Levetiracetam and clobazam can cause Drug Reaction with Eosinophilia and Systemic Symptoms, which can start as a rash but progress quickly, potentially resulting in injury to internal organs, hospitalization, and death.
Examining Barriers to Care in Diabetic Retinopathy Screening
November 30th 2023Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.
